Hippocrates | Quality and Compliance Expert in Life Sciences

06/30

June 30 ,2025

Annual Best Entrusted Mfg Quality Mgmt System(eMAH) Award

June 19, 2025, the 4th Pharmaceutical and Medical Device Digital Conference successfully concluded in Shanghai. This grand event brought together over 200 digital transformation pioneers from the pharmaceutical and medical device industries, including technical experts, market decision-makers, and operations managers. They jointly conducted in-depth discussions on industry digital transformation, providing key insights and cooperation opportunities for accelerating the intelligent upgrading of the industry.

01Conference Site

At the opening ceremony of the conference, representatives of the organizer emphasized the strategic significance of digital transformation for the pharmaceutical and medical device industries. Currently, the wave of technological advancement is reshaping the landscape of the global healthcare industry, and digital transformation has become the core driving force for enterprises to enhance competitiveness and drive innovative development. From drug R&D to clinical application, and from the production to distribution of medical devices, digital technologies are penetrating in all aspects, profoundly changing the operation models and development directions of the industry.

During the conference, focusing on the cutting-edge topic of "Exploration of the Application of Multimodal Integrated AI Large Models in the Pharmaceutical Field", experts pointed out that multimodal AI large models can integrate multi-source data such as clinical data, genomics information, and medical imaging. This provides more accurate target prediction and clinical trial design for drug R&D, and is expected to greatly shorten the R&D cycle and reduce costs. For instance, some leading pharmaceutical companies have successfully screened potential drug targets by virtue of this type of technology, significantly improving R&D efficiency.

On-site, a number of company representatives gave keynote speeches and shared experiences on topics including AI-empowered pharmaceutical transformation, digital and intelligent transformation of biopharmaceuticals, and application practices of generative AI, attracting hundreds of industry insiders from all over the country to participate in the event.

02 Hippocrates Health Technology Co., Ltd. won the industry award

During the award ceremony segment of this conference, Hippocrates Health Technology Co., Ltd. stood out by virtue of its strong technical strength and rich industry practical experience. The eMAH digital solution it launched won the "Annual Best Entrusted Manufacturing Quality Management System (eMAH)" Award. At the award presentation ceremony, Mr. Tan Jie, Vice President of Xingdi (1st from the left), took the stage on behalf of the company to receive the award. This award is not only a recognition of Xingdi's technological innovation in the field of digital production management, but also highlights the industry benchmark value of its solution in enhancing the compliance and efficiency of pharmaceutical entrusted manufacturing.

The successful holding of this conference not only built a communication platform for the digital transformation of the pharmaceutical and medical device industries, but also provided new opportunities for inter-enterprise cooperation and innovation. By bringing together industry wisdom and sharing cutting-edge technologies and practical experiences, the conference effectively promoted the process of digital transformation in the industry and injected strong impetus into achieving the goal of "Pharmaceutical innovation knows no bounds, AI empowers a new chapter". Looking ahead, with the continuous in-depth application of digital technologies, the pharmaceutical and medical device industries are expected to achieve more innovative breakthroughs and contribute more wisdom and strength to the development of global health initiatives.